Enliven Therapeutics Inc

NEW
NAS:ELVN (USA)  
$ 57.89 -0.84 (-1.43%) 11:08 PM EST
At Loss
P/B:
4.28
Market Cap:
$ 4.24B
Enterprise V:
$ 3.35B
Volume:
1.01M
Avg Vol (2M):
1.61M
Trade In:
Volume:
1.01M
At Loss
Avg Vol (2M):
1.61M

Enliven Therapeutics Inc (ELVN) Dividend

Enliven Therapeutics Inc (ELVN) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -13.1%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ELVN Dividend

Does Enliven Therapeutics Inc (ELVN) pay a dividend?

Enliven Therapeutics Inc (ELVN) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Enliven Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Enliven Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -13.1% over the past 3 years.

What are dividend-paying alternatives to Enliven Therapeutics Inc?

For dividend-paying alternatives in Enliven Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.